CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-04-05 | SCHIMMEL PAUL Director | Purchase | +25,000 | $3.52 | $88K | 37,572 |
| 2016-03-30 | Shukla Sanjay Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +163,000 | 163,000 | ||
| 2016-03-28 | Cubitt Andrew VP, Product Protection | Grant or award · Restricted Stock Unit | +13,000 | 13,000 | ||
| 2016-03-28 | Blackburn Kelly VP, Clinical Affairs | Grant or award · Restricted Stock Unit | +21,600 | 21,600 | ||
| 2016-01-27 | AKKARAJU SRINIVAS Director | Grant or award · Stock Option (right to buy) | +19,428 | 19,428 | ||
| 2016-01-27 | Nashat Amir Director | Grant or award · Stock Option (right to buy) | +19,428 | 19,428 | ||
| 2016-01-27 | Blackburn Stan Acting Chief Financial Officer | Grant or award · Stock Option (right to buy) | +4,250 | 4,250 | ||
| 2016-01-27 | SCHIMMEL PAUL Director | Grant or award · Stock Option (right to buy) | +19,428 | 19,428 | ||
| 2016-01-27 | Krueger Nancy VP, Legal Affairs | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2016-01-27 | Goldberg Mark Alan Director | Grant or award · Stock Option (right to buy) | +19,428 | 19,428 | ||
| 2016-01-27 | Ashlock Melissa A. See Remarks | Grant or award · Employee Stock Option (right to buy) | +18,250 | 18,250 | ||
| 2016-01-27 | FALBERG KATHRYN E Director | Grant or award · Stock Option (right to buy) | +19,428 | 19,428 | ||
| 2016-01-27 | Blackburn Kelly VP, Clinical Affairs | Grant or award · Employee Stock Option (right to buy) | +18,250 | 18,250 | ||
| 2016-01-27 | MENDLEIN JOHN CEO and Director | Grant or award · Employee Stock Option (right to buy) | +135,000 | 135,000 | ||
| 2016-01-27 | McKew John C. VP, Research | Grant or award · Employee Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2016-01-27 | CLARKE JOHN K Director | Grant or award · Stock Option (right to buy) | +19,428 | 19,428 | ||
| 2016-01-27 | Blake John T Vice President, Finance | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2016-01-27 | Chrzanowski Holly D. See Remarks | Grant or award · Employee Stock Option (right to buy) | +8,500 | 8,500 | ||
| 2016-01-27 | Cubitt Andrew VP, Product Protection | Grant or award · Employee Stock Option (right to buy) | +8,500 | 8,500 | ||
| 2016-01-27 | BLAIR JAMES C Director | Grant or award · Stock Option (right to buy) | +19,428 | 19,428 |
Page 16 of 25 · 483 trades